Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 91: A patient with drug overdose presents with pinpoint pupils, with BP 80/60 mm Hg, pulse 60 bpm with shallow respiration. Which of the following will be used for immediate treatment?

A. Naloxone (Correct Answer)
B. Naltrexone
C. Methadone
D. Pentazocine

Explanation: ### Explanation **Clinical Diagnosis: Acute Opioid Overdose** The patient presents with the classic **"Opioid Toxidrome"** triad [1]: 1. **Pinpoint pupils (Miosis)** 2. **Respiratory depression** (Shallow respiration) 3. **Altered mental status/CNS depression** (Hypotension and bradycardia are also common in severe cases). **Why Naloxone is the Correct Choice:** Naloxone is a **pure opioid antagonist** with a high affinity for $\mu$-receptors [2]. It is the drug of choice for **emergency reversal** of opioid overdose because it has a rapid onset of action (1–2 minutes IV) and effectively displaces opioids from their receptors, restoring spontaneous respiration [1]. **Analysis of Incorrect Options:** * **B. Naltrexone:** While also an opioid antagonist, it has high oral bioavailability and a **long duration of action**. It is used for the maintenance of opioid-free states (relapse prevention) and alcohol dependence, not for acute emergency reversal [2]. * **C. Methadone:** A long-acting **$\mu$-agonist** used in detoxification and maintenance therapy for opioid addiction. Administering this would worsen the toxicity. * **D. Pentazocine:** A **partial agonist/mixed agonist-antagonist**. It can precipitate withdrawal in an addict and would not effectively reverse a full-agonist overdose [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Short Half-life:** Naloxone has a shorter half-life (approx. 60–90 mins) than most opioids (e.g., Morphine, Heroin). **Observation is critical** because "re-narcotization" can occur as naloxone wears off, requiring repeat doses or an infusion [1]. * **Diagnostic Use:** Naloxone can be used as a diagnostic tool in a comatose patient when the cause of CNS depression is unknown [1]. * **Mydriasis Exception:** While most opioids cause miosis, **Meperidine (Pethidine)** is a notable exception that causes mydriasis (due to its atropine-like action).

Question 92: Which drug is contraindicated in patients with head injury?

A. Codeine
B. Pethidine
C. Morphine (Correct Answer)
D. Mannitol

Explanation: The primary reason **Morphine** (and most opioids) is contraindicated in head injury is its effect on respiration and intracranial pressure (ICP). 1. **Mechanism of Contraindication:** Morphine causes respiratory depression, leading to the accumulation of Carbon Dioxide ($CO_2$) [1]. Hypercapnia ($CO_2$ retention) acts as a potent cerebral vasodilator. This vasodilation increases cerebral blood flow, which subsequently **elevates Intracranial Pressure (ICP)**. In a head injury, where ICP is already compromised, this can lead to brain herniation. 2. **Diagnostic Interference:** Morphine causes **miosis** (pinpoint pupils) and sedation [1]. This masks critical neurological signs, such as pupillary changes and level of consciousness, which are essential for monitoring the progression of a head injury. **Analysis of Other Options:** * **Pethidine & Codeine:** While these are also opioids and generally avoided for similar reasons, **Morphine** is the classic textbook contraindication and the most potent respiratory depressant among the choices. In clinical practice, all potent opioids are used with extreme caution. * **Mannitol:** This is actually a **treatment** for head injury. It is an osmotic diuretic used to reduce cerebral edema and decrease elevated ICP. **High-Yield Clinical Pearls for NEET-PG:** * **Opioid Overdose Triad:** Miosis, Respiratory Depression, and Comatose state. * **Drug of Choice for Opioid Poisoning:** Naloxone (pure antagonist). * **Exception:** If a head injury patient requires mechanical ventilation, opioids may be used for sedation since the ventilator manages the $CO_2$ levels. * **Other Contraindications for Morphine:** Bronchial asthma, Undiagnosed acute abdomen, Biliary colic (causes sphincter of Oddi spasm), and Benign Prostatic Hyperplasia (BPH).

Question 93: Which of the following drugs can cause gynecomastia?

A. Digoxin
B. Ketoconazole
C. Spironolactone
D. All of the above (Correct Answer)

Explanation: **Explanation:** Gynecomastia (enlargement of male breast tissue) is a high-yield side effect in pharmacology, typically occurring due to an **alteration in the estrogen-to-androgen ratio**. This can happen via increased estrogen production, decreased testosterone synthesis, or displacement of hormones from their receptors. **Breakdown of Options:** * **Digoxin:** It has a steroid-like structure similar to estrogen. Chronic use can lead to increased estrogenic activity and decreased luteinizing hormone (LH), resulting in gynecomastia. * **Ketoconazole:** This antifungal inhibits the enzyme **17,20-desmolase** (and cytochrome P450 enzymes), which is essential for steroid synthesis. This leads to a significant reduction in testosterone production. * **Spironolactone:** A potassium-sparing diuretic that acts as a competitive antagonist at the androgen receptor. It also inhibits testosterone synthesis and increases the peripheral conversion of testosterone to estradiol. **Clinical Pearls for NEET-PG:** To remember the common drugs causing gynecomastia, use the mnemonic **"DISCO"** or **"STAC"**: * **S** – Spironolactone (Most common cause) * **T** – Testosterone/Theophylline * **A** – Alcohol/Amiodarone * **C** – Cimetidine (H2 blocker with anti-androgenic effects) * **K** – Ketoconazole * **D** – Digoxin **High-Yield Note:** Among these, **Spironolactone** is the most frequently cited drug in exams. If a patient develops painful gynecomastia while on Spironolactone, the clinical recommendation is to switch them to **Eplerenone**, which is a more selective aldosterone antagonist with fewer endocrine side effects.

Question 94: All of the following drugs may cause hyperkalemia except?

A. Cyclosporine
B. Amphotericin B (Correct Answer)
C. Heparin
D. NSAIDs

Explanation: **Explanation:** The correct answer is **Amphotericin B**. This drug is a classic cause of **hypokalemia** (low potassium), not hyperkalemia. **1. Why Amphotericin B is the correct answer:** Amphotericin B is a polyene antifungal that increases the permeability of the distal renal tubular membrane. This leads to **Type 1 (Distal) Renal Tubular Acidosis (RTA)**. The increased membrane permeability causes a significant leak of potassium and magnesium into the urine, resulting in profound hypokalemia and hypomagnesemia. **2. Why the other options are incorrect (Causes of Hyperkalemia):** * **Cyclosporine:** This immunosuppressant causes hyperkalemia by inhibiting the action of aldosterone on the principal cells of the collecting duct and inducing renal tubular resistance to mineralocorticoids. * **Heparin:** Heparin (both UFH and LMWH) inhibits the synthesis of aldosterone in the adrenal cortex by reducing the number and affinity of angiotensin II receptors in the zona glomerulosa. * **NSAIDs:** These drugs inhibit prostaglandin synthesis. Prostaglandins (PGE2 and PGI2) normally stimulate renin release. By suppressing the Renin-Angiotensin-Aldosterone System (RAAS), NSAIDs reduce potassium excretion. **High-Yield Clinical Pearls for NEET-PG:** * **"K-Sparing" mnemonic for Hyperkalemia:** **K**-sparing diuretics (Spironolactone), **S**uccinylcholine, **P**rimarine (Heparin), **A**CE inhibitors/ARBs, **R**enal failure, **I**nfection/Inflammation (NSAIDs), **N**ephrotoxicity (Cyclosporine), **G**lucose (Beta-blockers). * **Amphotericin B Toxicity:** Often referred to as "Ampho-terrible" due to its side effects: Nephrotoxicity, Hypokalemia, Hypomagnesemia, and Infusion-related reactions (Chills/Rigors). * **Heparin-induced hyperkalemia** can occur even with low doses and typically manifests within 3–5 days of starting therapy.

Question 95: Vacuolar degeneration and myofibrillar loss of cardiac muscle is caused by:

A. Interferon alfa
B. Trastuzumab
C. Cyclophosphamide
D. Doxorubicin (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Doxorubicin** Doxorubicin (an Anthracycline) causes cardiotoxicity through the generation of **iron-dependent free radicals** (reactive oxygen species). These radicals cause lipid peroxidation of the myocardial cell membrane. Histopathologically, this is characterized by **vacuolar degeneration** (Sarcoplasmic reticulum swelling) and **myofibrillar loss** (loss of contractile elements). There are two types of Doxorubicin cardiotoxicity: 1. **Acute:** Transient ECG changes (arrhythmias, ST-T changes). 2. **Chronic:** Dose-dependent dilated cardiomyopathy leading to congestive heart failure (CHF). The risk increases significantly once the cumulative dose exceeds **450–550 mg/m²**. **Why other options are incorrect:** * **A. Interferon alfa:** Primarily associated with flu-like symptoms, depression, and myelosuppression; it does not typically cause myofibrillar loss. * **B. Trastuzumab:** Causes Type II cardiotoxicity. Unlike Doxorubicin, it is **not dose-dependent**, does not cause structural damage (no vacuolar degeneration), and is usually **reversible** upon discontinuation. * **C. Cyclophosphamide:** High doses (used in bone marrow transplants) can cause acute hemorrhagic cystitis or acute myocarditis/pericarditis, but it is not the classic cause of chronic myofibrillar loss. **NEET-PG High-Yield Pearls:** * **Antidote:** **Dexrazoxane** (an iron chelator) is used to prevent/reduce Doxorubicin-induced cardiotoxicity. * **Monitoring:** The most sensitive gold standard for monitoring is an **Endomyocardial biopsy**, though clinically, **Echocardiography (LVEF)** is more common. * **Liposomal Doxorubicin:** Formulated to reduce cardiotoxicity by altering drug distribution.

Question 96: Which of the following statements about bupivacaine is incorrect?

A. It is less cardiotoxic than lignocaine. (Correct Answer)
B. Its toxicity can be increased by adrenaline.
C. It has a long duration of action.
D. It cannot be given intravenously.

Explanation: ### Explanation **1. Why Option A is the Correct (Incorrect Statement):** Bupivacaine is significantly **more cardiotoxic** than lignocaine. While lignocaine is used as an anti-arrhythmic, bupivacaine has a high affinity for voltage-gated sodium channels in the myocardium and dissociates slowly during diastole ("slow-in, slow-out" kinetics). This leads to severe ventricular arrhythmias and cardiovascular collapse that is notoriously difficult to resuscitate. **2. Analysis of Other Options:** * **Option B (Toxicity and Adrenaline):** While adrenaline is often added to local anesthetics to prolong action via vasoconstriction, it can worsen bupivacaine-induced cardiotoxicity by enhancing the risk of ventricular arrhythmias and tachycardia. * **Option C (Duration of Action):** Bupivacaine is a long-acting amide local anesthetic. It is highly lipid-soluble and protein-bound, providing anesthesia for 3–6 hours, which is much longer than lignocaine (1–2 hours). * **Option D (Intravenous Administration):** Bupivacaine is strictly contraindicated for intravenous use (e.g., IV Regional Anesthesia/Bier’s Block) due to the high risk of systemic toxicity and cardiac arrest. **3. High-Yield Clinical Pearls for NEET-PG:** * **Lipid Rescue:** Intravenous **Lipid Emulsion (20%)** is the specific antidote for bupivacaine-induced systemic toxicity (LAST). * **Levobupivacaine & Ropivacaine:** These are S-enantiomers developed to provide similar long-acting anesthesia but with a **lower risk** of cardiotoxicity compared to racemic bupivacaine. * **Potency:** Bupivacaine is roughly 4 times more potent than lignocaine. * **Differential Block:** At low concentrations, bupivacaine produces a sensory block with minimal motor block, making it ideal for **obstetric analgesia** (painless labor).

Question 97: Necrosis of proximal convoluted tubules is caused by:

A. Arsenic
B. Phenol (Correct Answer)
C. Alcohol
D. Amanita phalloides

Explanation: **Explanation:** **Phenol (Carbolic Acid)** is a potent corrosive and a systemic toxin. When ingested or absorbed through the skin, it causes severe coagulative necrosis. While its local effects are prominent, its systemic toxicity is characterized by central nervous system depression and acute renal failure. Specifically, phenol and its metabolites are excreted via the kidneys, where they cause direct toxic damage leading to **Acute Tubular Necrosis (ATN)**, primarily affecting the **proximal convoluted tubules (PCT)**. This often manifests clinically as oliguria and the presence of "smoky" or green-colored urine (due to oxidation products like hydroquinone). **Analysis of Incorrect Options:** * **Arsenic:** While arsenic is a potent nephrotoxin, its primary renal manifestation is typically acute tubular necrosis associated with hemoglobinuria (secondary to hemolysis) or glomerular damage, rather than isolated PCT necrosis. * **Alcohol (Ethanol):** Ethanol does not directly cause PCT necrosis. Renal damage associated with alcohol is usually indirect, resulting from rhabdomyolysis (leading to myoglobinuric ATN) or chronic liver disease (Hepatorenal Syndrome). * **Amanita phalloides:** This "Death Cap" mushroom contains **amatoxins** (alpha-amanitin). Its primary target is the **liver**, causing massive hepatic necrosis by inhibiting RNA polymerase II. While multi-organ failure can involve the kidneys, the hallmark pathology is fulminant hepatic failure. **High-Yield NEET-PG Pearls:** * **Phenol Poisoning:** Characterized by the "carbolic odor," corrosion of mucous membranes (white patches), and "Carboluria" (greenish-black urine). * **Other PCT Toxins:** Mercury (corrosive sublimate), Aminoglycosides, and Cisplatin are also classic causes of PCT necrosis. * **Distinction:** Ethylene glycol causes PCT necrosis with characteristic **calcium oxalate crystals** in the tubular lumen.

Question 98: Which of the following drugs causes nephrotoxicity and hypertension, similar to cyclosporine?

A. Azathioprine
B. Cyclophosphamide
C. Mycophenolate mofetil
D. Tacrolimus (Correct Answer)

Explanation: **Explanation:** The correct answer is **Tacrolimus (D)**. Both Cyclosporine and Tacrolimus belong to the class of **Calcineurin Inhibitors (CNIs)**. Their mechanism involves inhibiting calcineurin, which prevents the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells), thereby decreasing IL-2 production and T-cell activation. Because they share the same mechanism of action, they also share a similar side-effect profile. The most characteristic toxicities of CNIs are **nephrotoxicity** (due to afferent arteriolar vasoconstriction) and **hypertension**. While Tacrolimus is more potent and associated with a higher incidence of post-transplant diabetes mellitus (neurotoxicity/hyperglycemia), it mirrors Cyclosporine’s renal and vascular adverse effects. **Analysis of Incorrect Options:** * **A. Azathioprine:** A purine antimetabolite. Its primary dose-limiting toxicity is **bone marrow suppression** (leukopenia) and potential hepatotoxicity. It does not cause hypertension or significant nephrotoxicity. * **B. Cyclophosphamide:** An alkylating agent. Its signature toxicity is **hemorrhagic cystitis** (prevented by Mesna) and bone marrow suppression. * **C. Mycophenolate mofetil (MMF):** Inhibits IMDH (Inosine Monophosphate Dehydrogenase). Its main side effects are **gastrointestinal** (diarrhea, vomiting) and hematological (pancytopenia). It is notably "renal-sparing." **NEET-PG High-Yield Pearls:** * **Gingival Hyperplasia & Hirsutism:** Common with Cyclosporine, but **absent** with Tacrolimus. * **Diabetes Mellitus:** More common with Tacrolimus than Cyclosporine. * **Drug of Choice:** Tacrolimus is currently preferred over Cyclosporine for most solid organ transplants due to superior efficacy and a slightly better cosmetic profile.

Question 99: Which of the following drugs is NOT hepatotoxic?

A. Erythromycin estolate
B. Rifampicin
C. Tetracycline
D. Linezolid (Correct Answer)

Explanation: **Explanation:** The correct answer is **Linezolid**. Hepatotoxicity is a common adverse effect of many antimicrobial agents, but Linezolid is primarily known for its hematological and neurological toxicities rather than hepatic damage. **1. Why Linezolid is the correct answer:** Linezolid, an Oxazolidinone, is not typically associated with significant hepatotoxicity. Its primary dose-limiting side effect is **bone marrow suppression** (especially thrombocytopenia) when used for more than 2 weeks. It is also associated with peripheral/optic neuropathy and **Serotonin Syndrome** when co-administered with SSRIs due to its weak MAO-inhibitory activity. **2. Why the other options are wrong:** * **Erythromycin estolate:** This specific salt of Erythromycin is notorious for causing **cholestatic jaundice**. It is considered a hypersensitivity reaction and is more common in adults than children. * **Rifampicin:** A key component of ATT (Anti-Tubercular Therapy), it is a known hepatotoxin. It causes an asymptomatic rise in transaminases and can lead to clinical hepatitis. It is also a potent **enzyme inducer**. * **Tetracycline:** High doses (especially IV) can cause **acute fatty liver infiltration**, particularly in pregnant women, which can be fatal. **Clinical Pearls for NEET-PG:** * **Drug-Induced Liver Injury (DILI):** Paracetamol (Acetaminophen) is the most common cause of dose-dependent hepatotoxicity (treated with N-acetylcysteine). * **ATT Hepatotoxicity:** The order of hepatotoxicity is **Isoniazid > Pyrazinamide > Rifampicin**. Ethambutol is non-hepatotoxic. * **Halothane:** A classic anesthetic agent associated with "Halothane Hepatitis." * **Valproate:** Can cause idiosyncratic hepatotoxicity, especially in children under 2 years.

Question 100: Nephrotoxicity is a known side effect of which of the following immunosuppressives?

A. Sirolimus
B. Tacrolimus (Correct Answer)
C. Mycophenolate mofetil
D. Azathioprine

Explanation: **Explanation:** The correct answer is **Tacrolimus (Option B)**. Tacrolimus and Cyclosporine belong to the class of **Calcineurin Inhibitors (CNIs)**. Their primary mechanism involves inhibiting calcineurin, which prevents the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells), thereby reducing IL-2 production. **Nephrotoxicity** is the most significant dose-limiting side effect of CNIs. It occurs via two mechanisms: 1. **Acute:** Potent vasoconstriction of the afferent arterioles leading to decreased GFR (reversible). 2. **Chronic:** Progressive interstitial fibrosis and tubular atrophy (often irreversible). **Analysis of Incorrect Options:** * **A. Sirolimus (mTOR Inhibitor):** Unlike CNIs, Sirolimus is notably **non-nephrotoxic**. Its primary toxicities are hyperlipidemia, thrombocytopenia, and impaired wound healing. It is often used as an alternative to Tacrolimus in patients with declining renal function. * **C. Mycophenolate Mofetil (Inhibits IMDH):** Its main side effects are **gastrointestinal** (diarrhea, vomiting) and hematological (leukopenia). It does not cause renal damage. * **D. Azathioprine (Purine Analog):** Its major toxicity is **bone marrow suppression** (pancytopenia). It is metabolized by Xanthine Oxidase; thus, its dose must be reduced if given with Allopurinol. **High-Yield Clinical Pearls for NEET-PG:** * **Tacrolimus vs. Cyclosporine:** Tacrolimus is more potent and has a higher incidence of **New-Onset Diabetes After Transplantation (NODAT)** and neurotoxicity, whereas Cyclosporine is more associated with gingival hyperplasia and hirsutism. * **Monitoring:** Both CNIs require Therapeutic Drug Monitoring (TDM) due to their narrow therapeutic index. * **Drug Interactions:** Both are metabolized by **CYP3A4**; enzyme inhibitors (e.g., Ketoconazole, Erythromycin) can increase their levels, worsening nephrotoxicity.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free